Identification of Ultrasonic Echolucent Carotid Plaques Using Discrete Fréchet Distance Between Bimodal Gamma
IEEE Transactions on Bio-Medical Engineering
|March 10, 2017
Summary
A new computer-aided method effectively identifies echolucent carotid plaques using discrete Fréchet distance features. This approach shows promise for improving cardiovascular and cerebrovascular event risk prediction in patients with atherosclerotic plaques.
Area of Science:
- Medical Imaging
- Biomedical Engineering
- Cardiovascular Research
Background:
- Echolucent carotid plaques are linked to acute cardiovascular and cerebrovascular events (ACCEs).
- Accurate identification of plaque echogenicity is crucial for risk stratification.
- Current noninvasive methods may require enhancement for precise plaque characterization.
Purpose of the Study:
- To develop and evaluate a computer-aided method for identifying echolucent carotid plaques.
- To assess the feasibility of using discrete Fréchet distance features (DFDFs) for plaque classification.
- To enhance the noninvasive ultrasonic assessment of ACCE risk in patients with atherosclerosis.
Main Methods:
- A dataset of 315 carotid plaque ultrasound images (echolucent, echo-rich, intermediate) was analyzed.
- A bimodal gamma distribution modeled pixel statistics, and DFDFs were extracted.
- Linear discriminant analysis identified most discriminative features (MDFs) for k-nearest-neighbor classification.
Main Results:
- The developed method achieved a 77.46% classification accuracy for the three plaque types.
- The area under the receiver operating characteristics curve for identifying echolucent plaques was 0.831.
- The results demonstrate the potential of DFDFs in differentiating plaque echogenicity.
Conclusions:
- The computer-aided method based on DFDFs shows feasibility for identifying echolucent carotid plaques.
- This technique may improve the noninvasive ultrasonic prediction of ACCEs in patients with atherosclerotic plaques.
- Further validation could integrate this method into routine clinical practice for enhanced cardiovascular risk assessment.


